B Shannon1,2, P Gajer3,4, T J Yi1,2, B Ma3,4, M S Humphrys3, J Thomas-Pavanel5, L Chieza5, P Janakiram5, M Saunders5, W Tharao5, S Huibner1, K Shahabi1, J Ravel3,4, R Kaul1,2,6. 1. Department of Medicine, and. 2. Department of Immunology, University of Toronto, Ontario, Canada. 3. Institute for Genome Sciences, University of Maryland School of Medicine, and. 4. Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore. 5. Women's Health in Women's Hands Community Health Centre, and. 6. University Health Network (RK), Toronto, Ontario, Canada.
Abstract
Background: Genital inflammation is a key determinant of human immunodeficiency virus (HIV) transmission, and may increase HIV-susceptible target cells and alter epithelial integrity. Several genital conditions that increase HIV risk are more prevalent in African, Caribbean, and other black (ACB) women, including bacterial vaginosis and herpes simplex virus type-2 (HSV-2) infection. Therefore, we assessed the impact of the genital microbiota on mucosal immunology in ACB women and microbiome-HSV-2 interactions. Methods: Cervicovaginal secretions and endocervical cells were collected by cytobrush and Instead Softcup, respectively. T cells and dendritic cells were assessed by flow cytometry, cytokines by multiplex enzyme-linked immunosorbent assay (ELISA), and the microbiota by 16S ribosomal ribonucleic acid gene sequencing. Results: The cervicovaginal microbiota of 51 participants were composed of community state types (CSTs) showing diversity (20/51; 39%) or predominated by Lactobacillus iners (22/51; 42%), L. crispatus (7/51; 14%), or L. gasseri (2/51; 4%). High-diversity CSTs and specific bacterial phyla (Gardnerella vaginalis and Prevotella bivia) were strongly associated with cervicovaginal inflammatory cytokines, but not with altered endocervical immune cells. However, cervical CD4+ T-cell number was associated with HSV-2 infection and a distinct cytokine profile. Conclusions: This suggests that the genital microbiota and HSV-2 infection may influence HIV susceptibility through independent biological mechanisms.
Background: Genital inflammation is a key determinant of human immunodeficiency virus (HIV) transmission, and may increase HIV-susceptible target cells and alter epithelial integrity. Several genital conditions that increase HIV risk are more prevalent in African, Caribbean, and other black (ACB) women, including bacterial vaginosis and herpes simplex virus type-2 (HSV-2) infection. Therefore, we assessed the impact of the genital microbiota on mucosal immunology in ACB women and microbiome-HSV-2 interactions. Methods: Cervicovaginal secretions and endocervical cells were collected by cytobrush and Instead Softcup, respectively. T cells and dendritic cells were assessed by flow cytometry, cytokines by multiplex enzyme-linked immunosorbent assay (ELISA), and the microbiota by 16S ribosomal ribonucleic acid gene sequencing. Results: The cervicovaginal microbiota of 51 participants were composed of community state types (CSTs) showing diversity (20/51; 39%) or predominated by Lactobacillus iners (22/51; 42%), L. crispatus (7/51; 14%), or L. gasseri (2/51; 4%). High-diversity CSTs and specific bacterial phyla (Gardnerella vaginalis and Prevotella bivia) were strongly associated with cervicovaginal inflammatory cytokines, but not with altered endocervical immune cells. However, cervical CD4+ T-cell number was associated with HSV-2 infection and a distinct cytokine profile. Conclusions: This suggests that the genital microbiota and HSV-2 infection may influence HIV susceptibility through independent biological mechanisms.
Authors: Melis N Anahtar; Elizabeth H Byrne; Kathleen E Doherty; Brittany A Bowman; Hidemi S Yamamoto; Magali Soumillon; Nikita Padavattan; Nasreen Ismail; Amber Moodley; Mary E Sabatini; Musie S Ghebremichael; Chad Nusbaum; Curtis Huttenhower; Herbert W Virgin; Thumbi Ndung'u; Krista L Dong; Bruce D Walker; Raina N Fichorova; Douglas S Kwon Journal: Immunity Date: 2015-05-19 Impact factor: 31.745
Authors: Samuel Biraro; Philippe Mayaud; Rhoda Ashley Morrow; Heiner Grosskurth; Helen A Weiss Journal: Sex Transm Dis Date: 2011-02 Impact factor: 2.830
Authors: Jessica L Prodger; Ronald Gray; Godfrey Kigozi; Fred Nalugoda; Ronald Galiwango; Kighoma Nehemiah; Moses Kakanga; Taha Hirbod; Maria J Wawer; Nelson Sewankambo; David Serwadda; Rupert Kaul Journal: AIDS Date: 2012-06-19 Impact factor: 4.177
Authors: Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley Journal: J Infect Dis Date: 2006-04-26 Impact factor: 5.226
Authors: Suzanna C Francis; Yanwen Hou; Kathy Baisley; Janneke van de Wijgert; Deborah Watson-Jones; Trong T Ao; Carolina Herrera; Kaballa Maganja; Aura Andreasen; Saidi Kapiga; Gary R Coulton; Richard J Hayes; Robin J Shattock Journal: PLoS One Date: 2016-01-27 Impact factor: 3.240
Authors: Kristine M Wylie; Todd N Wylie; Alison G Cahill; George A Macones; Methodius G Tuuli; Molly J Stout Journal: Am J Obstet Gynecol Date: 2018-05-05 Impact factor: 8.661
Authors: Laura E Richert-Spuhler; Laura Pattacini; Margot Plews; Elizabeth Irungu; Timothy R Muwonge; Elly Katabira; Nelly Mugo; Adrienne F A Meyers; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund Journal: AIDS Date: 2019-11-15 Impact factor: 4.177
Authors: Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger Journal: Viruses Date: 2022-05-27 Impact factor: 5.818
Authors: Jessica L Prodger; Alison G Abraham; Aaron Ar Tobian; Daniel E Park; Maliha Aziz; Kelsey Roach; Ronald H Gray; Lane Buchanan; Godfrey Kigozi; Ronald M Galiwango; Joseph Ssekasanvu; James Nnamutete; Joseph Kagaayi; Rupert Kaul; Cindy M Liu Journal: JCI Insight Date: 2021-04-22
Authors: Christina A Muzny; Paweł Łaniewski; Jane R Schwebke; Melissa M Herbst-Kralovetz Journal: Curr Opin Infect Dis Date: 2020-02 Impact factor: 4.968